ClinicalTrials.Veeva

Menu
U

University Multiprofile Hospital for Active Treatment Sofiamed | Neurology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
Cetuximab
Encorafenib

Parent organization

This site is a part of University Multiprofile Hospital for Active Treatment Sofiamed

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 5 total trials

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

The purpose of this study is to evaluate two study medicines (encorafenib plus cetuximab) taken alone or together with standard chemotherapy for the...

Active, not recruiting
Neoplasms
Drug: Cetuximab
Drug: Oxaliplatin

The primary objective of this study is to compare the efficacy of ABP 234 with the pembrolizumab reference product (Keytruda®).

Enrolling
Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
Drug: ABP 234
Drug: Pembrolizumab (EU)

The primary objective of this study is to demonstrate pharmacokinetic (PK) similarity ABP 234 with pembrolizumab.

Enrolling
Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
Drug: ABP 234
Drug: Pembrolizumab
Locations recently updated

Study to evaluate the efficacy, safety and tolerability of ponsegromab compared to placebo in patients with cancer, cachexia, and elevated GDF 15.

Active, not recruiting
Loss of Appetite
Non-small Cell Lung Cancer
Drug: Placebo for ponsegromab
Drug: ponsegromab

Trial sponsors

Amgen logo
Pfizer logo
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems